Health
Johnson & Johnson Covid-19 Vaccine Updates: Lower Weekly Supply, Blood Clot Investigations – Trefis
Johnson & Johnson (NYSE:JNJ) began the rollout of its single-dose Covid-19 vaccine in the United States in early March 2021. Below are some of the recent updates…
Johnson & Johnson (NYSE:JNJ) began the rollout of its single-dose Covid-19 vaccine in the United States in early March 2021. Below are some of the recent updates relating to the vaccine.
The supply of J&J’s Covid-19 vaccine is expected to decline by about 85% in the U.S. this week, as the company faces some manufacturing challenges. Total supply through the U.S. is likely to stand at about 1.5 million doses, down from 11 million for last week. That said, the company says that it is on track to…
-
Business24 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business23 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News20 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
General7 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A